Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatitis, Allergic Contact | 5 | 2006 | 104 | 0.800 |
Why?
|
| Patch Tests | 5 | 2006 | 53 | 0.660 |
Why?
|
| Dermatitis, Irritant | 2 | 2006 | 17 | 0.570 |
Why?
|
| Sebaceous Glands | 3 | 2000 | 41 | 0.400 |
Why?
|
| Lichen Planus | 3 | 2000 | 57 | 0.400 |
Why?
|
| Laser Therapy | 6 | 2000 | 1072 | 0.380 |
Why?
|
| Microscopy, Confocal | 4 | 2006 | 1970 | 0.370 |
Why?
|
| Laser Coagulation | 3 | 1997 | 326 | 0.340 |
Why?
|
| Household Products | 1 | 2006 | 26 | 0.280 |
Why?
|
| Facial Dermatoses | 2 | 1996 | 87 | 0.240 |
Why?
|
| PUVA Therapy | 3 | 1991 | 98 | 0.220 |
Why?
|
| Lichenoid Eruptions | 1 | 2000 | 14 | 0.190 |
Why?
|
| Leg Dermatoses | 1 | 2000 | 20 | 0.190 |
Why?
|
| Skin | 8 | 2000 | 4372 | 0.180 |
Why?
|
| Sebaceous Gland Diseases | 1 | 1999 | 5 | 0.170 |
Why?
|
| Dermatitis, Contact | 1 | 1999 | 129 | 0.170 |
Why?
|
| Remote Consultation | 2 | 1999 | 238 | 0.170 |
Why?
|
| Anesthesia, Local | 2 | 1998 | 275 | 0.160 |
Why?
|
| Onychomycosis | 1 | 1998 | 47 | 0.160 |
Why?
|
| Nail Diseases | 1 | 1998 | 51 | 0.160 |
Why?
|
| Prilocaine | 1 | 1998 | 19 | 0.160 |
Why?
|
| Anesthetics, Combined | 1 | 1998 | 40 | 0.160 |
Why?
|
| Allergens | 2 | 2001 | 1320 | 0.150 |
Why?
|
| Hand Dermatoses | 1 | 1996 | 61 | 0.140 |
Why?
|
| Granuloma, Pyogenic | 1 | 1996 | 48 | 0.140 |
Why?
|
| Sensation | 1 | 1998 | 336 | 0.130 |
Why?
|
| Nevus, Pigmented | 1 | 1997 | 219 | 0.130 |
Why?
|
| Lasers | 3 | 1998 | 952 | 0.120 |
Why?
|
| Lidocaine | 1 | 1998 | 544 | 0.120 |
Why?
|
| Amyloidosis | 1 | 2000 | 796 | 0.110 |
Why?
|
| Telangiectasis | 1 | 1992 | 76 | 0.100 |
Why?
|
| Dermatology | 2 | 1999 | 872 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 1998 | 1257 | 0.100 |
Why?
|
| Anesthetics, Local | 1 | 1998 | 985 | 0.090 |
Why?
|
| Photochemotherapy | 4 | 1984 | 807 | 0.090 |
Why?
|
| Neodymium | 3 | 1998 | 21 | 0.090 |
Why?
|
| Aluminum Silicates | 3 | 1998 | 26 | 0.090 |
Why?
|
| Yttrium | 3 | 1998 | 35 | 0.090 |
Why?
|
| Photosensitivity Disorders | 2 | 1986 | 78 | 0.080 |
Why?
|
| Erythema Nodosum | 1 | 1986 | 30 | 0.070 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2007 | 97 | 0.070 |
Why?
|
| Arsenic Poisoning | 1 | 2007 | 55 | 0.070 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 1986 | 49 | 0.070 |
Why?
|
| Leprosy | 1 | 1986 | 124 | 0.070 |
Why?
|
| Internet | 1 | 1999 | 3056 | 0.070 |
Why?
|
| Hyperplasia | 2 | 2000 | 1185 | 0.070 |
Why?
|
| Skin Neoplasms | 3 | 2007 | 5692 | 0.070 |
Why?
|
| Skin Diseases | 3 | 1999 | 1066 | 0.070 |
Why?
|
| Administration, Cutaneous | 2 | 1998 | 711 | 0.060 |
Why?
|
| Psoriasis | 2 | 1991 | 902 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2007 | 595 | 0.060 |
Why?
|
| Skin Pigmentation | 2 | 1996 | 282 | 0.060 |
Why?
|
| Communication Barriers | 1 | 2006 | 398 | 0.060 |
Why?
|
| Tattooing | 2 | 1996 | 58 | 0.060 |
Why?
|
| Mass Screening | 1 | 1998 | 5253 | 0.050 |
Why?
|
| Alopecia | 1 | 1986 | 382 | 0.050 |
Why?
|
| Adult | 22 | 2007 | 214052 | 0.050 |
Why?
|
| Dinitrobenzenes | 1 | 2001 | 37 | 0.050 |
Why?
|
| Arthritis | 1 | 1986 | 661 | 0.050 |
Why?
|
| Professional-Patient Relations | 1 | 2006 | 737 | 0.050 |
Why?
|
| Mucinosis, Follicular | 1 | 2000 | 8 | 0.050 |
Why?
|
| Etretinate | 1 | 2000 | 6 | 0.050 |
Why?
|
| Aluminum Oxide | 2 | 1997 | 42 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2006 | 14723 | 0.050 |
Why?
|
| Middle Aged | 16 | 2006 | 213390 | 0.040 |
Why?
|
| Sebum | 1 | 1999 | 16 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2001 | 1386 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 1782 | 0.040 |
Why?
|
| Hair Removal | 1 | 1999 | 42 | 0.040 |
Why?
|
| Mycosis Fungoides | 1 | 2000 | 163 | 0.040 |
Why?
|
| Blister | 1 | 1999 | 86 | 0.040 |
Why?
|
| Langerhans Cells | 1 | 1999 | 173 | 0.040 |
Why?
|
| Humans | 33 | 2007 | 744366 | 0.040 |
Why?
|
| Ointments | 1 | 1998 | 59 | 0.040 |
Why?
|
| Organizational Case Studies | 1 | 1999 | 299 | 0.040 |
Why?
|
| Dermis | 1 | 1999 | 207 | 0.040 |
Why?
|
| Videotape Recording | 1 | 1999 | 352 | 0.040 |
Why?
|
| Computer Systems | 1 | 1999 | 483 | 0.040 |
Why?
|
| Cell Size | 1 | 1999 | 643 | 0.040 |
Why?
|
| Female | 20 | 2007 | 380193 | 0.040 |
Why?
|
| Curettage | 1 | 1996 | 73 | 0.040 |
Why?
|
| Eczema | 1 | 1999 | 231 | 0.040 |
Why?
|
| Desiccation | 1 | 1996 | 71 | 0.040 |
Why?
|
| Massachusetts | 3 | 1999 | 8662 | 0.040 |
Why?
|
| Electrosurgery | 1 | 1996 | 58 | 0.040 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1998 | 392 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2006 | 2278 | 0.030 |
Why?
|
| Mechanoreceptors | 1 | 1998 | 186 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2000 | 799 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4328 | 0.030 |
Why?
|
| Necrosis | 1 | 2000 | 1643 | 0.030 |
Why?
|
| Epidermis | 1 | 1999 | 528 | 0.030 |
Why?
|
| Hyperpigmentation | 1 | 1997 | 112 | 0.030 |
Why?
|
| Male | 20 | 2007 | 350115 | 0.030 |
Why?
|
| Cicatrix | 3 | 1996 | 764 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1998 | 506 | 0.030 |
Why?
|
| Esthetics | 1 | 1996 | 306 | 0.030 |
Why?
|
| Edema | 1 | 1999 | 789 | 0.030 |
Why?
|
| Vasodilation | 1 | 1999 | 944 | 0.030 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 1999 | 455 | 0.030 |
Why?
|
| Recurrence | 2 | 1999 | 8340 | 0.030 |
Why?
|
| Hospitals, General | 1 | 1998 | 749 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1986 | 2104 | 0.030 |
Why?
|
| Myiasis | 1 | 1993 | 15 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1998 | 1590 | 0.030 |
Why?
|
| Pain Threshold | 1 | 1998 | 584 | 0.030 |
Why?
|
| Photography | 1 | 1997 | 520 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2000 | 3914 | 0.030 |
Why?
|
| Fats | 1 | 1993 | 102 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 1997 | 39052 | 0.030 |
Why?
|
| Aged | 9 | 2006 | 163288 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 1998 | 2029 | 0.030 |
Why?
|
| Adolescent | 6 | 2007 | 85779 | 0.030 |
Why?
|
| Remission Induction | 1 | 1997 | 2385 | 0.020 |
Why?
|
| Biopsy | 2 | 2000 | 6755 | 0.020 |
Why?
|
| Physical Examination | 1 | 1997 | 1237 | 0.020 |
Why?
|
| Meat | 1 | 1993 | 592 | 0.020 |
Why?
|
| Erythema | 1 | 1991 | 257 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1999 | 2969 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2001 | 2219 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1996 | 1487 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 1992 | 434 | 0.020 |
Why?
|
| Desipramine | 1 | 1988 | 184 | 0.020 |
Why?
|
| Darier Disease | 1 | 1987 | 12 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 1999 | 2725 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2000 | 63107 | 0.020 |
Why?
|
| Atrophy | 1 | 1992 | 1584 | 0.020 |
Why?
|
| Societies, Medical | 1 | 1999 | 3743 | 0.020 |
Why?
|
| Cell Movement | 1 | 1999 | 5218 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 1998 | 57776 | 0.020 |
Why?
|
| Connecticut | 1 | 2006 | 366 | 0.020 |
Why?
|
| Water Supply | 1 | 2007 | 214 | 0.020 |
Why?
|
| Latin America | 1 | 2006 | 380 | 0.020 |
Why?
|
| Acculturation | 1 | 2006 | 182 | 0.020 |
Why?
|
| Drug Eruptions | 1 | 1988 | 297 | 0.020 |
Why?
|
| Registries | 1 | 1999 | 8091 | 0.010 |
Why?
|
| Incidence | 2 | 1999 | 20952 | 0.010 |
Why?
|
| Arsenic | 1 | 2007 | 328 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1999 | 15078 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 1998 | 19905 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 18034 | 0.010 |
Why?
|
| Primary Health Care | 1 | 1999 | 4557 | 0.010 |
Why?
|
| Prevalence | 1 | 1998 | 15221 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1999 | 8949 | 0.010 |
Why?
|
| India | 1 | 2007 | 2197 | 0.010 |
Why?
|
| Causality | 1 | 2007 | 1275 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2005 | 8319 | 0.010 |
Why?
|
| Methoxsalen | 1 | 1979 | 21 | 0.010 |
Why?
|
| Tars | 1 | 1978 | 20 | 0.010 |
Why?
|
| Risk Assessment | 1 | 1999 | 23336 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1996 | 7182 | 0.010 |
Why?
|
| Age Factors | 2 | 1992 | 18373 | 0.010 |
Why?
|
| Child | 4 | 2006 | 77709 | 0.010 |
Why?
|
| Language | 1 | 2006 | 1471 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1988 | 2708 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 6459 | 0.010 |
Why?
|
| Keloid | 1 | 1996 | 50 | 0.010 |
Why?
|
| Pigmentation Disorders | 1 | 1996 | 101 | 0.010 |
Why?
|
| Furunculosis | 1 | 1993 | 6 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1997 | 40559 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2007 | 9849 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1996 | 15297 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 3395 | 0.010 |
Why?
|
| Ethiopia | 1 | 1996 | 495 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 12952 | 0.010 |
Why?
|
| United States | 1 | 1999 | 69872 | 0.010 |
Why?
|
| Animals | 2 | 2001 | 168768 | 0.010 |
Why?
|
| Time Factors | 3 | 2000 | 40075 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 21748 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1990 | 876 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 25628 | 0.000 |
Why?
|
| Internship and Residency | 1 | 2006 | 5791 | 0.000 |
Why?
|
| Risk Factors | 2 | 2007 | 72296 | 0.000 |
Why?
|
| Infant | 1 | 2006 | 35134 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2006 | 41005 | 0.000 |
Why?
|
| Disease Progression | 1 | 2000 | 13286 | 0.000 |
Why?
|
| Swine | 1 | 1993 | 5918 | 0.000 |
Why?
|
| Ultraviolet Therapy | 1 | 1978 | 81 | 0.000 |
Why?
|
| Anxiety Disorders | 1 | 1988 | 2690 | 0.000 |
Why?
|
| Depressive Disorder | 1 | 1988 | 3747 | 0.000 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 1988 | 3658 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1987 | 12961 | 0.000 |
Why?
|
| Pain | 1 | 1978 | 4988 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1988 | 77460 | 0.000 |
Why?
|
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_